
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104
Keywords: Small cell lung cancer; Phase II; Carboplatin; Etoposide; Exisulind; CALGB